Marrow-Tech Inc. (NASDAQ:MAROA) on Thursday said it hasbeen awarded a $50,000 Phase I small business innovationresearch grant from the National Institutes of Health as partof the NIH Skin Diseases Program. The La Jolla, Calif., companywill use the grant to research innovative applications for itsDermagraft transplantable human skin tissue.

(c) 1997 American Health Consultants. All rights reserved.